Amicus Therapeutics Inc (FOLD.OQ)

FOLD.OQ on NASDAQ Stock Exchange Global Market

2.49USD
4:00pm EDT
Price Change (% chg)

$0.05 (+2.05%)
Prev Close
$2.44
Open
$2.46
Day's High
$2.50
Day's Low
$2.44
Volume
163,568
Avg. Vol
89,957
52-wk High
$6.81
52-wk Low
$2.06

FOLD.OQ

Chart for FOLD.OQ

About

Amicus Therapeutics, Inc. (Amicus) is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered, small molecule drugs known as pharmacological chaperones for treating a range of diseases, including lysosomal storage diseases and diseases of neurodegeneration. It is focused on... (more)

Overall

Beta: 1.08
Market Cap (Mil.): $121.10
Shares Outstanding (Mil.): 49.63
Dividend: --
Yield (%): --

Financials

  FOLD.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -1.09 -- --
ROI: -56.42 -2.58 18.76
ROE: -79.20 -2.66 19.59
Search Stocks

Competitors

  Price Change
Sanofi SA (SASY.PA) €76.85 -3.32
Shire PLC (SHP.L) 2,440.00p +38.00
Shire PLC (3159084.L) -- --
Actelion Ltd (ATLN.VX) CHF61.50 +0.50
Protalix BioTherapeutics Inc. (PLX.TA) 1,912.00₪ -22.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Wright Reports
$460.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks